Quanterix Names PBL Preferred Partner | GenomeWeb

NEW YORK (GenomeWeb) – Quanterix this week named PBL Assay Science a preferred partner for assay research and development. 

Leveraging Quanterix's Simoa — a single-molecule array immunoassay technology for detecting and quantifying antigens and proteins — PBL will be able to enter new markets and strengthen its current product offerings, Quanterix said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.